China’s National Medical Products Administration (NMPA) has approved Zeiss Medical Technology’s retinal imaging system, the ...

Boehringer Ingelheim has taken an option on a family ... that spans both pharmacological and digital therapeutic (DTx) products. Leading the charge for new drug therapies is iclepertin (also ...

NPPA sets retail prices for 41 drug combinations, including 18 variants of off-patent diabetes drug empagliflozin, following steep price drops post-patent expiry ...

Financial Stability: Eli Lilly's balance sheet is more robust, with debt making up only 4% of equity, considerably less than ...

Poultry vaccines are available to producers who need to control  Bronchitis, Bursal Disease, Encephalitis, Fowl Pox, Laryngotracheitis, Marek's Disease, ...

King & Spalding still has about 175 products liability lawyers worldwide and another 130 specializing in toxic and ...

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

In new guidance, NICE has cleared NHS use of Boehringer Ingelheim's clot-busting therapy ... It was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in April for ...

The global canine arthritis treatment market stands at a valuation of USD 2.50 billion in 2024. Global demand for canine arthritis treatment medications is predicted to rise at a CAGR of 4.20% and ...

DelveInsight's Chronic Kidney Disease pipeline report depicts a robust space with 75+ active players working to develop 80+ ...

Researchers bring new understanding to how unfoldases and deubiquitinating enzymes coordinate to regulate protein degradation ...

As multiple companies vie to expand on Alnylam’s success in commercializing RNAi therapeutics, the pioneering company has set ...